Roth Capital Downgrades LifeCell Corp. (LIFC) to Hold

April 9, 2008 10:52 AM EDT

Roth Capital downgrades LifeCell Corp. (Nasdaq: LIFC) from Buy to Hold.

LifeCell Corporation develops, processes and markets biological soft tissue repair products made from human (allograft) and animal (xenograft) tissue.[SM]


Related Categories

Downgrades

Stocks Mentioned

LIFC 51.05

+0.00 +0.00%
Volume: 0
Track LIFC


Related Entities


Add Your Comment





Follow StreetInsider.com On Twitter